OncoMutational ratio on ctDNA: A potential novel biomarker in NSCLC

被引：0
|
作者：
Ambrosini, P. [1 ]
Provenzano, L. [1 ]
Bottiglieri, A. [1 ]
Spagnoletti, A. [1 ]
Di Guida, G. [2 ]
Mazzeo, L. [1 ]
Beninato, T. [1 ]
Leporati, R. [3 ]
Occhipinti, M. [4 ]
Brambilla, M. [1 ]
Manglaviti, S. [1 ]
Ganzinelli, M. [4 ]
Miskovic, V. [5 ]
Proto, C. [1 ]
Dumitrascu, A. D. [1 ]
De Braud, F. G. M. [6 ]
Della Corte, C. M. [7 ]
Lo Russo, G. [8 ]
Viscardi, G. [9 ]
Prelaj, A. [10 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy
[2] Univ Campania Luigi Vanvitelli, Med Oncol Dept, Caserta, Italy
[3] Ist Nazl Tumori Milano Fdn IRCCS, Oncol Dept, Milan, Italy
[4] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[5] Politecn Milan, Dipartimento Elettron Informaz & Bioingegneria, Milan, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Med Oncol & Haematol Dept, Milan, Italy
[7] Univ Campania Luigi Vanvitelli, Dipartimento Oncol, Naples, Italy
[8] Fdn IRCCS Ist Nazl Tumori, Dipartimento Oncol Toraco Polmonare, Milan, Italy
[9] Univ Campania Luigi Vanvitelli, Dipartimento Oncol Medica, Naples, Italy
[10] Fdn IRCCS Ist Nazl Tumori, Oncol Medica Torac Dept, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68P
引用
收藏
页码：S79 / S80
页数：2
相关论文
共 50 条
  • [31] Serum β-klotho is a potential biomarker in the prediction of clinical outcomes among patients with NSCLC
    Zhou, Juan
    Ben, Suqin
    Xu, Tan
    Xu, Liqin
    Yao, Xin
    JOURNAL OF THORACIC DISEASE, 2021, 13 (05) : 3137 - 3150
  • [32] Low-level gastrokine 2 promoted progress of NSCLC and as a potential biomarker
    Yang, Xiang
    Shi, Wenjing
    Zhou, Huixin
    Huang, Xiaolou
    Hu, Lijuan
    Feng, Jiang
    Wang, Yumin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (02)
  • [33] Serum Proteomic Signature as a Potential Biomarker for Survival in Patients with NSCLC Receiving Immunotherapy
    Kim, W. B.
    Viveiros, P.
    Anker, J.
    Simon, N.
    Rhee, K.
    Song, J.
    Cho, A.
    Chang, S.
    Ko, T.
    Oh, M.
    Davis, A.
    Park, L. C.
    Chae, Y. K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S793 - S794
  • [34] Plasma circulating ctDNA: Potential biomarker in non-small cell lung carcinoma and clinical significance
    Goel, V.
    Tiwari, S.
    Talwar, V.
    Pattnaik, N.
    Dash, P.
    Raina, S.
    John, M. C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S29 - S29
  • [35] Endocan, novel potential biomarker for multiple sclerosis?
    Akil, E.
    Alp, R.
    Ozdemir, H. H.
    Arslan, D.
    Cevik, M. U.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 192 - 192
  • [36] APLN: A potential novel biomarker for cervical cancer
    Chen, Yusha
    Lin, Xiaoqian
    Zheng, Jinwen
    Chen, Jiancui
    Xue, Huifeng
    Zheng, Xiangqin
    SCIENCE PROGRESS, 2021, 104 (02)
  • [37] Cathepsin Z as a novel potential biomarker for osteoporosis
    Dera, Ayed A.
    Ranganath, Lakshminarayan
    Barraclough, Roger
    Vinjamuri, Sobhan
    Hamill, Sandra
    Barraclough, Dong L.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [38] BORIS: A potential novel breast cancer biomarker
    Apte, A.
    Chandrasekharan, S.
    Klenova, E.
    CANCER RESEARCH, 2013, 73
  • [39] Calprotectin as potential novel biomarker in myasthenia gravis
    Stascheit, Frauke
    Hotter, Benjamin
    Hoffmann, Sarah
    Kohler, Siegfried
    Lehnerer, Sophie
    Sputtek, Andreas
    Meisel, Andreas
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2021, 4
  • [40] Cathepsin Z as a novel potential biomarker for osteoporosis
    Ayed A. Dera
    Lakshminarayan Ranganath
    Roger Barraclough
    Sobhan Vinjamuri
    Sandra Hamill
    Dong L. Barraclough
    Scientific Reports, 9
12345